Tudor Investment Corp ET AL Invests $24.36 Million in KalVista Pharmaceuticals, Inc. $KALV
Tudor Investment Corp ET AL bought a new stake in shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Free Report) during the 3rd quarter, HoldingsChannel reports. The institutional investor bought 2,000,000 shares of the specialty pharmaceutical company’s stock, valued at approximately $24,360,000. A number of other institutional investors also recently bought and sold shares of the […]
21 Mar 11:44 · The Markets Daily